SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Kalyan Ram Bhamidimarri, MD, MPH
Associate Professor/ Transplant Hepatology
University of Miami/ Miami Transplant Institute
Miami, FL

Gregg Sherman, MD
Family Practice
Plantation, FL

: Recognition and Management of Primary Biliary Cholangitis (PBC): A Chronic Inflammatory Liver Disease
Activity/Course #:
: NCME359
: Free
Release/Start Date:
: Oct 08 2018
Expiration Date:
: Oct 07 2019
: Gastroenterology
Target Audience:
: Primary Care Physicians, Nurse Practitioners and Physician Assistants
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s)
Hardware/Software Requirements:

Program Summary:

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic inflammatory disease of the liver, which if untreated results in end-stage biliary cirrhosis and portal hypertension, with associated symptoms and negative effects on quality of life (QoL). It is most prevalent in women aged >50 years, with the dual effects of age and sex leading to a prevalence of PBC being as high as 1 in 800 in women aged >45 years. Evaluation and timely diagnosis are important because treatment is available for PBC and some of its symptoms.

This activity will review the epidemiology and pathophysiology of PBC,  and identify strategies for evaluation and treatment.

This webcast was recorded live at the Emerging Challenges in Primary Care 2018 Live Virtual Symposium and is being used with the permission of the presenters.

Learning Objectives

After completing this program participants should be able to:

  1. Review the epidemiology of primary biliary cholangitis (PBC)
  2. Describe the pathophysiology of PBC
  3. Recognize how to evaluate a patient for PBC
  4. Discuss the treatment of PBC, including the treatment of extrahepatic manifestations

 How to obtain the CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hour of continuing education which includes 0.25 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Kalyan Ram Bhamidimarri, MD, MPH serves on the scientific advisory board for Gilead, AbbVie, Merck, and Intercept Pharmaceuticals, Inc.

Activity Planning Commitee
Gregg Sherman, MD, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationship to disclose.

Harvey C. Parker, Ph.D., has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Sheila Lucas, CWEP, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationship to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.
Commercial Support
This activity is supported by an independent educational grant from Intercept Pharmaceuticals, Inc.